Works matching IS 11707690 AND DT 2021 AND VI 39 AND IP 12


Results: 9
    1
    2
    3
    4
    5
    6

    Early Cost Effectiveness of Whole-Genome Sequencing as a Clinical Diagnostic Test for Patients with Inoperable Stage IIIB,C/IV Non-squamous Non-small-Cell Lung Cancer.

    Published in:
    PharmacoEconomics, 2021, v. 39, n. 12, p. 1429, doi. 10.1007/s40273-021-01073-y
    By:
    • Simons, Martijn J. H. G.;
    • Retèl, Valesca P.;
    • Ramaekers, Bram L. T.;
    • Butter, Rogier;
    • Mankor, Joanne M.;
    • Paats, Marthe S.;
    • Aerts, Joachim G. J. V.;
    • Mfumbilwa, Zakile A.;
    • Roepman, Paul;
    • Coupé, Veerle M. H.;
    • Uyl-de Groot, Carin A.;
    • van Harten, Wim H.;
    • Joore, Manuela A.
    Publication type:
    Article
    8
    9